|
Re: New breast cancer vaccine provides evidence of immunotherapy in preventing diseas
This is indeed exciting news; I wish I could have been on the trial.
So what is the Phase III part of a trial? Will they enroll new patients or just continue following the original cohort?
Also, 'Lizbeth, do you know if the vaccines have to be administered within a certain length of time after completing treatment with Herceptin? I'm just wondering if this will impact those of us who finished treatment already.
Shirley
__________________
- Age 54 at dx (April '13) Stage 2b, grade 3
- ER+ PR+ HER+, 9 cm tumor one breast and <0.5 cm in sentinal node
- BRCA1 and 2 negative
- Neoadjuvant TCH chemo started 5-15-13 (4 rounds, 3 weeks apart)
- Unilateral Mx w/expander 8-22-13 (right side)
- 5/5 nodes Neg
- clear margins but close. Tumor at removal down to 2.2 cm.
- Radiation 6 wks starting 10-17-13.
- Herceptin every 3 weeks until 4-23-14
- DIEP/Mastopexy 10-8-14, U of WA
|